Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia.
about
Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort studyWHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothersAntiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South AfricaInduction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in childrenFirst-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine.Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapineAntiretroviral use during pregnancy for treatment or prophylaxis.Efavirenz-based combination antiretroviral therapy after peripartum single-dose nevirapine.Factors for incomplete adherence to antiretroviral therapy including drug refill and clinic visits among older adults living with human immunodeficiency virus - cross-sectional study in South Africa.
P2860
Q28472889-42627BDC-A281-41A7-8FD0-28949C41D1A5Q28478406-4A0214C8-36F7-499A-A5CB-CAE313794A70Q33537373-B10E569E-CDD6-450F-8D0D-5C827CD7E7F3Q34699162-A1ED1ED7-4C6E-44FC-9FCA-5A6B37C36FCBQ34748599-5AFEE2E2-45DF-46EB-8036-DAAAFF12C10FQ35021860-D10EB2D1-76C3-4C99-87D2-EB90CB5B76C0Q35965722-7B921809-0D97-4E85-9F81-A601DD28816AQ35990257-9E84E972-1271-48FE-A4FB-B14CFE76C5D6Q37870932-A872AF51-805B-475E-B801-7866D15ABFC5Q43467646-C59255DE-3DF0-4994-A4B1-A8D8D600A964Q47304804-22032E7C-F395-4CF6-83D3-090621AED388
P2860
Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mortality and virologic outcom ...... nevirapine in Lusaka, Zambia.
@en
Mortality and virologic outcom ...... nevirapine in Lusaka, Zambia.
@nl
type
label
Mortality and virologic outcom ...... nevirapine in Lusaka, Zambia.
@en
Mortality and virologic outcom ...... nevirapine in Lusaka, Zambia.
@nl
prefLabel
Mortality and virologic outcom ...... nevirapine in Lusaka, Zambia.
@en
Mortality and virologic outcom ...... nevirapine in Lusaka, Zambia.
@nl
P2093
P2860
P50
P921
P1476
Mortality and virologic outcom ...... nevirapine in Lusaka, Zambia.
@en
P2093
Don Decker
Grace M Aldrovandi
Mwiya Mwiya
Prisca Kasonde
Shobana Ramachandran
P2860
P304
P356
10.1097/QAI.0B013E3181AB6D5E
P407
P577
2009-09-01T00:00:00Z